![Cytek Biosciences Inc](/common/images/company/N_CTKB.png)
Cytek Biosciences Inc (CTKB)
NASDAQ
The current CTKB market cap is 817.83M. The company's latest EPS is USD -0.0925 and P/E is -67.35.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | ||
Total Revenue | 37.09M | 49.69M | 48M | 58.23M | 44.86M |
Operating Income | -12.16M | -9.13M | -6.42M | -1.64M | -10.73M |
Net Income | -6.81M | -4.39M | -6.46M | 5.5M | -6.17M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 92.84M | 127.95M | 164.04M | 193.02M |
Operating Income | 13.66M | 9.16M | -1.8M | -27.85M |
Net Income | 3.22M | 0 | 2.58M | -12.15M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | ||
Total Assets | 524.58M | 525.05M | 519.43M | 494.46M | 492.07M |
Total Liabilities | 101.12M | 100.88M | 103.91M | 101.39M | 99.45M |
Total Equity | 423.46M | 424.18M | 415.52M | 393.06M | 392.61M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 219.98M | 463.31M | 519.48M | 494.46M |
Total Liabilities | 41.69M | 57.92M | 93.93M | 101.39M |
Total Equity | -16.03M | 405.39M | 425.55M | 393.06M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | ||
Operating | 2.86M | 8k | -4.23M | 5.28M | 3.96M |
Investing | -168.87M | -166.08M | -122.96M | -93.89M | -5.75M |
Financing | N/A | 216k | -8.06M | -41.81M | 1.61M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 15.16M | 4.63M | -12.23M | 5.28M |
Investing | -1.55M | -20.99M | -55.91M | -93.89M |
Financing | 122.61M | 213.56M | 5.51M | -41.81M |
Market Cap | 817.83M |
Price to Earnings Ratio | -67.35 |
Price to Sales Ratio | 4.24 |
Price to Cash Ratio | 4.89 |
Price to Book Ratio | 2.08 |
Dividend Yield | - |
Shares Outstanding | 131.27M |
Average Volume (1 week) | 610.29k |
Average Volume (1 Month) | 517.1k |
52 Week Change | -30.00% |
52 Week High | 9.87 |
52 Week Low | 3.80 |
Spread (Intraday) | 0.09 (1.43%) |
Company Name | Cytek Biosciences Inc |
Address |
850 new burton road dover, delaware 19904 |
Website | https://www.cytekbio.com |
Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.